drugset / Trial / NCT07442006
Glycemic Variability of Combination Therapies in T2DM
RandomizedParallel-groupOpen-labelTreatment
Summary
Glycemic Variability of Combination Therapies in T2DM
Timeline
- Start
- 2025-10-29
- Primary completion
- 2027-03-31
- Completion
- 2027-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Anagliptin | Small molecule | 100 mg | Oral |
| Subject | Empagliflozin | Small molecule | 5 mg | Oral |
| Subject | Empagliflozin | Small molecule | 10 mg | Oral |
| Comparator | Linagliptin | Small molecule | 5 mg | Oral |
| Subject | Metformin | Small molecule | 500 mg | Oral |
| Subject | Metformin | Small molecule | 1000 mg | Oral |